Prognostic factor analysis and clinical significance of HER‑2‑positive breast cancers with negative lymph nodes and a tumor diameter ≤1 cm

The 2021 National Comprehensive Cancer Network guidelines recommend that adjuvant chemotherapy combined with trastuzumab be considered for human epidermal growth factor receptor 2 (HER-2)-positive breast cancer patients with small tumors (tumor diameter ≤1 cm) and negative lymph nodes. Additionally,...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Shanshan, Wang, Yongnan, Guo, Yujuan, Zhang, Yan, Peng, Haiyan, Tang, Huang, Luo, Yizhong, Zhang, Anqin, Gao, Hongyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579976/
https://www.ncbi.nlm.nih.gov/pubmed/37854866
http://dx.doi.org/10.3892/ol.2023.14078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579976/
https://www.ncbi.nlm.nih.gov/pubmed/37854866
http://dx.doi.org/10.3892/ol.2023.14078

Ejemplares similares